“Therapeutic Antibody Half-Life Extension: Engineering Choices and Their Clinical Consequences”. Translational Medicine & Therapeutics Journal, vol. 5, no. 1, July 2026, pp. 74-82, https://doi.org/10.5281/zenodo.22649501.